论文著作：
1. Jun Ni, Xiaofei Wang, Yue Shang, Yi Li, Shu-zhen Chen*. CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner. Cancer Biol Med, 2021, 18(2):569-586.
2. Xinran Qiao, Chen Wang, Wendie Wang, Yue Shang, Yi Li, Jun Ni, Shu-zhen Chen*. Levamisole enhances DR4-independent apoptosis induced by TRAIL through inhibiting the activation of JNK in lung cancer. Life Sci. 2020; 257: 118034.
3. Zhijuan Ge, Dong Liu, Yue Shang, Yi Li, Shu-zhen Chen*. Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro. J Nat Med. 2020, 74(4):741-749.
4. Wendie Wang, Yue Shang, Yi Li,Shu-zhen Chen*. Honokiol Inhibits Breast Cancer Cell Metastasis by Blocking EMT through Modulation of Snail/Slug Protein Translation. Acta Pharmacol Sin, 2019, 40(9): 1219-1227.
5. Dong Liu, Xinran Qiao, Zhijuan Ge, Yue Shang, Yi Li, Wendie Wang, Minghua Chen, Shuyi Si, Shu-zhen Chen*. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway. Skelet Muscle, 2019, 9: 8.
6. Dong Liu, Yi Li, Yue Shang, Wendie Wang, Shu-zhen Chen*. Effect of brown adipose tissue/cells on the growth of mouse hepatocellular carcinoma in vitro and in vivo. Oncol Lett, 2019,17(3): 3203-3210.
7. Xinran Qiao, Maoluo Gan, Chen Wang, Bin Liu, Yue Shang, Yi Li, Shuzhen Chen*. Tetracenomycin X Exerts Antitumour Activity in Lung Cancer Cells through the Downregulation of Cyclin D1. Mar. Drugs, 2019, 17(1): 63.
8. Xinran Qiao, Xiaofei Wang, Yue Shang, Yi Li, Shu-zhen Chen*. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo. Cancer Commun (Lond). 2018, 38(1): 43.
9. Xiaofei Wang, Xinran Qiao, Yue Shang, Shenghua Zhang, Yi Li, Hongwei He, Shu-zhen Chen*. RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo. Amino Acids. 2017,49(5), 931-941.
10.Xiaoqin Lv, Xinran Qiao, Ling Su, Shu-zhen Chen*. Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP. Acta Pharmacol Sin, 2016, 37(12): 1574-1586.
发明专利：
1.朱大强，陈淑珍，王晓飞，商悦，李毅，李良. 一种双靶点双弹头抗肿瘤融合蛋白、其编码基因和用途.专利号：ZL201310566310.5；申请日：2013.11.14；授权日：2019.06.21
2.陈淑珍，王晓飞，乔新然，商悦，张胜华，李毅，何红伟. 一种抗肿瘤侵袭转移的多靶点融合蛋白的制备和用途. 专利申请号：201610924303.1；申请日：2016.10.24
3.陈淑珍，刘栋，李毅，商悦，王文蝶. 一种新型的肝癌生物治疗方法. 专利申请号：201810068605.2；申请日：2018.01.24；授权日：2020.11.06
4.陈淑珍, 刘栋, 乔新然, 葛治娟, 商悦, 李毅, 王文蝶, 陈明华, 司书毅. 一种抗癌症恶病质的化合物及应用. 专利号：ZL201810561181.3；申请日：2018.06.04；授权日：2019.10.25
5.陈淑珍，倪隽，商悦，李毅.一种含乌苯美司和TRAIL蛋白的抗肿瘤组合物及其应用.专利申请号：201810897991.6；申请日：2018.08.08
陈淑珍
北京市
研究领域：
生物医药
研究方向：
肿瘤药理学和分子免疫学
所在单位：
中国医学科学院北京协和医学院
